SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Rantapää Dahlqvist Solveig)
 

Search: WFRF:(Rantapää Dahlqvist Solveig) > (2015-2019) > Co-morbidity in pat...

  • Innala, Lena,1060-Umeå universitet,Reumatologi (author)

Co-morbidity in patients with early rheumatoid arthritis - inflammation matters

  • Article/chapterEnglish2016

Publisher, publication year, extent ...

  • 2016-01-28
  • BioMed Central,2016
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-117189
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-117189URI
  • https://doi.org/10.1186/s13075-016-0928-yDOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: Patients with rheumatoid arthritis (RA) suffer from co-morbidities that contribute to a shortened lifespan. Inflammation is important for the development of cardiovascular disease, but little is known on its relationship with other co-morbidities. We investigated the role of inflammation for the development of new comorbidities in early RA. Methods: Since 1995, all patients with early RA in Northern Sweden are included in a prospective study on comorbidities, with a total of 950 patients being included. At the time for this study, 726 had been ill for >= 5 years. Data on co-morbidities, clinical and laboratory disease activity and pharmacological therapy were collected from patient records and further validated using a questionnaire at RA onset (T0) and after 5 years (T5). Results: Of the patients, 53.2 % of the patients had one or more co-morbidity at onset, the commonest being: hypertension (27.3 %), obstructive pulmonary disease (13.9 %), diabetes (8.0 %), hypothyroidism (6.3 %) and malignancy (5.0 %). After 5 years, 41.0 % had developed at least one new co-morbidity, the most common being: hypertension (15.1 %), malignancy (7.6 %), stroke/transient ischemic accident (5.1 %), myocardial infarction (4.3 %) and osteoporosis (3.7 %). Age at disease onset, a raised erythrocyte sedimentation rate (ESR) at inclusion, previous treatment with glucocorticoids (GC; p < 0.001 for all), extra-articular RA (Ex-RA; p < 0.01), DAS28 (area under the curve) at 24 months (p < 0.05), previous smoking at inclusion (p = 0.058) and male gender (p < 0.01) were associated with a new co-morbidity overall at T5. Treatment with biologics (p < 0.05) reduced the risk. In multiple logistic regression modelling, ESR (p = 0.036) at inclusion was associated with a new co-morbidity after 5 years, adjusted for age, sex, smoking and GC treatment. In a similar model, Ex-RA (p < 0.05) was associated with a new co-morbidity at T5. In a third model, adjusted for age and sex, a new pulmonary co-morbidity was associated with a smoking history at inclusion (p < 0.01), but not with ESR. Conclusion: There was substantial co-morbidity among early RA patients already at disease onset, with considerable new co-morbidity being added during the first five years. Measures of disease activity were associated with the occurrence of a new co-morbidity indicating that the inflammation is of importance in this context.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Sjöberg, Clara,1986-Umeå universitet,Reumatologi(Swepub:umu)clsj0002 (author)
  • Möller, Bozena (author)
  • Ljung, Lotta,1964-Umeå universitet,Reumatologi(Swepub:umu)LJLO0001 (author)
  • Smedby, Torgny (author)
  • Södergren, Anna,1977-Umeå universitet,Reumatologi(Swepub:umu)anayxt97 (author)
  • Magnusson, Staffan (author)
  • Rantapää-Dahlqvist, Solbritt,1947-Umeå universitet,Reumatologi(Swepub:umu)sora0001 (author)
  • Wållberg-Jonsson, Solveig,1953-Umeå universitet,Reumatologi(Swepub:umu)sowa0001 (author)
  • Umeå universitetReumatologi (creator_code:org_t)

Related titles

  • In:Arthritis Research & Therapy: BioMed Central181478-6362

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view